Washington: A combination of symptom and viral rebound after untreated COVID-19 infection is rare, occurring in only three per cent of study participants, an analysis of a COVID-19 trial has found.

Widespread use of nirmatrelvir -- a recommended treatment for outpatients with mild

to moderate COVID-19 -- has been accompanied by reports of worsening symptoms and virologic rebound after treatment completion, the researchers said.

Virologic rebound has also been reported in persons who did not receive nirmatrelvir therapy, they said.

No Comments For This Post, Be first to write a Comment.
Leave a Comment
Enter the code shown:

Can't read the image? click here to refresh

Todays Epaper

English Weekly

neerus indian ethnic wear
Latest Urdu News

Should KCR hand over his political legacy to son KTR?

Can't Say